Skip to content

Parenteral Nutrition Cycling for Prevention of Cholestatic Syndrome in Newborn

Parenteral Nutrition Cycling for Prevention of Cholestatic Syndrome in Newborn

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06366880
Enrollment
66
Registered
2024-04-16
Start date
2024-03-11
Completion date
2025-12-15
Last updated
2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholestasis in Newborn

Keywords

Parenteral nutrition cycling, Incidence of colestasis, Incidence of hypoglycemia, Hospital-acquired infections, Randomised controlled trial

Brief summary

Background: Despite the use of parenteral nutrition cycling (PNC) in neonatal intensive care units (NICU), there is limited evidence regarding the benefits in relation to the nutrición parenteral total (NPT) in term and late preterm infants. The recommendations from the recently published Latin American Society of Gastroenterology, Hepatology and Pediatric Nutrition guidelines are substantially different in this area, and surveys have reported variations in clinical practice. The aim of this randomised controlled trial (RCT) is to evaluate the benefits and risks of PNC AND parenteral nutrition total (NPT) in term and late preterm infants.

Detailed description

Methods/design: This study is a single-centre, non-blinded RCT in the NICU of Pediatric Hospital of Sinaloa, Northwest, Mexico. A total of 66 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 10 days will be randomised to PNC o PNT after informed parental consent. In both groups, EN will be commenced as early as clinically feasible. Primary outcomes Incidence of colestasis on Day 28 of admission. Secondary outcomes are total plasma bilirrubine profiles, the incidence of hypoglycemia, hospital-acquired infections, length of hospital/NICU stay, in-hospital all-cause mortality, weight, height and head circumference. Discussion: This RCT will examine the effects of NPTC versus late PNT in term and late preterm infants by comparing key biochemical and clinical outcomes and has the potential to identify underlying pathways for beneficial or harmful effects related to both treatments. Trial registration: 2022.HPS.DI.434 (3rd March 2024) Keywords: Parenteral nutrition cycling, Incidence of colestasis, incidence of hypoglycaemia, hospital-acquired infections, Randomised controlled trial.

Interventions

OTHERParenteral nutrition cycling

This study is a single-centre, non-blinded RCT in the NICU of Pediatric Hospital of Sinaloa, Northwest, Mexico. A total of 66 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 10 days will be randomised to PNC o PNT after informed parental consent. In both groups, EN will be commenced as early as clinically feasible.

Sponsors

Hospital Pediátrico de Sinaloa
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Hours to 28 Days
Healthy volunteers
No

Inclusion criteria

* Chylothorax * Intestinal obstruction * Intestinal malrotation * Intestinal intussusception * Gastroschisis * Intestinal volvulus * Duodenal atresia * Enterocolitis * Sepsis * Septic shock * Prolonged fast * Authorization of the study by parents

Exclusion criteria

* Presence of liver diseases or malformations that cause cholestasis. * All patients who have received medical treatment for cholestasis are excluded.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of cholestasis on Day 28 of admission.Day 1 to 28Proportion of cholestasis

Secondary

MeasureTime frameDescription
are total plasma bilirrubine profilesDay 1 to 28mg/dl
the incidence of hypoglycaemiaDay 1 to 28mg/dl

Countries

Mexico

Contacts

Primary ContactAna Karen Camargo Angulo, Dr.
anakarencamargo96@gmail.com6681890586
Backup ContactClaudia Gamez, PhD
claudia_ge89@hotmail.com6871353192

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026